GC0000151A - 2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide. - Google Patents

2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide.

Info

Publication number
GC0000151A
GC0000151A GCP20001052A GC0000151A GC 0000151 A GC0000151 A GC 0000151A GC P20001052 A GCP20001052 A GC P20001052A GC 0000151 A GC0000151 A GC 0000151A
Authority
GC
Cooperation Council for the Arab states of the Gulf
Prior art keywords
isobutyramide
morpholin
pyridin
tolyl
trifluoromethyl
Prior art date
Application number
Other languages
English (en)
Inventor
Theresa Maria Ballard
Guy Andrew Higgins
Torsten Hoffmann
Sonia Maria Poli
Andrew Sleight
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of GC0000151A publication Critical patent/GC0000151A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
GCP20001052 1999-11-29 2000-11-26 2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide. GC0000151A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99123685 1999-11-29

Publications (1)

Publication Number Publication Date
GC0000151A true GC0000151A (en) 2005-06-29

Family

ID=8239481

Family Applications (1)

Application Number Title Priority Date Filing Date
GCP20001052 GC0000151A (en) 1999-11-29 2000-11-26 2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide.

Country Status (50)

Country Link
EP (1) EP1103545B1 (hu)
JP (1) JP3480835B2 (hu)
KR (1) KR100390117B1 (hu)
CN (1) CN1152016C (hu)
AR (1) AR033659A1 (hu)
AT (1) ATE253561T1 (hu)
AU (1) AU775292B2 (hu)
BG (1) BG64622B1 (hu)
BR (1) BRPI0005616B8 (hu)
CA (1) CA2326529C (hu)
CO (1) CO5251405A1 (hu)
CZ (1) CZ299286B6 (hu)
DE (2) DE60006340T2 (hu)
DK (1) DK1103545T3 (hu)
DO (1) DOP2000000106A (hu)
EA (1) EA004404B1 (hu)
ES (2) ES2208205T3 (hu)
FR (1) FR2801590A1 (hu)
GB (1) GB2356863A (hu)
GC (1) GC0000151A (hu)
GE (1) GEP20022763B (hu)
GT (1) GT200000197A (hu)
HK (1) HK1036759A1 (hu)
HR (1) HRP20000809A2 (hu)
HU (1) HU224703B1 (hu)
ID (1) ID28483A (hu)
IL (1) IL139868A (hu)
IS (1) IS2212B (hu)
IT (1) IT1320120B1 (hu)
JO (1) JO2298B1 (hu)
MA (1) MA26754A1 (hu)
MX (1) MXPA00011672A (hu)
MY (1) MY127426A (hu)
NO (1) NO317264B1 (hu)
NZ (1) NZ508386A (hu)
OA (1) OA11513A (hu)
PA (1) PA8507201A1 (hu)
PE (1) PE20010901A1 (hu)
PL (1) PL195957B1 (hu)
PT (1) PT1103545E (hu)
SG (1) SG97171A1 (hu)
SI (1) SI1103545T1 (hu)
SK (1) SK285373B6 (hu)
SV (1) SV2002000227A (hu)
TN (1) TNSN00226A1 (hu)
TR (1) TR200302077T4 (hu)
UA (1) UA70326C2 (hu)
UY (1) UY26458A1 (hu)
YU (1) YU73400A (hu)
ZA (1) ZA200006964B (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20013046A3 (cs) 1999-02-24 2002-02-13 F. Hoffmann-La Roche Ag Fenylové a pyridinylové deriváty
SE1035115T5 (sv) * 1999-02-24 2015-08-04 Hoffmann La Roche 4-fenylpyridin-derivat och deras anvaendning som NK-1 receptor-antagonister
MXPA03000366A (es) * 2000-07-14 2003-05-27 Hoffmann La Roche N-oxidos como profarmacos antagonistas del receptor nk1 de derivados de 4-fenil-piridina.
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
BR0307257A (pt) * 2002-01-31 2004-12-14 Hoffmann La Roche Polimorfismos genéticos no gene da pré-pró-taquicinina
PL1643998T3 (pl) 2003-07-03 2008-01-31 Hoffmann La Roche Podwójni antagoniści NK1/NK3 do leczenia schizofrenii
US7288658B2 (en) 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
WO2006002860A1 (en) 2004-07-06 2006-01-12 F. Hoffmann-La Roche Ag Process for preparing carboxamide pyridine derivatives used as intermediates in the synthesis of nk-1 receptor antagonists
RU2007129642A (ru) 2005-02-25 2009-03-27 Ф.Хоффманн-Ля Рош Аг (Ch) Таблетки с улучшенным распределением лекарственного вещества
PT1863767E (pt) * 2005-03-23 2009-03-27 Hoffmann La Roche Metabolitos para antagonistas de nk-1 para vómitos
MY143784A (en) 2005-09-23 2011-07-15 Hoffmann La Roche Novel dosage formulation
US8093268B2 (en) 2007-01-24 2012-01-10 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl-benzyl)-(2S-phenylpiperidin-3S-yl-)
US8426450B1 (en) * 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
BR112015021982B1 (pt) 2013-03-15 2022-12-13 Global Blood Therapeutics, Inc Compostos e seus usos para a modulação de hemoglobina
AU2014347644B2 (en) 2013-11-08 2018-06-14 Kissei Pharmaceutical Co., Ltd. Carboxymethyl piperidine derivative
CN114181195A (zh) 2014-02-07 2022-03-15 全球血液疗法股份有限公司 一种化合物的结晶多晶型物
TWI649307B (zh) 2014-05-07 2019-02-01 日商橘生藥品工業股份有限公司 Cyclohexylpyridine derivative
KR101948238B1 (ko) 2016-08-19 2019-02-14 (주)케어젠 미녹시딜과 펩타이드의 결합체

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919245A3 (en) * 1991-09-20 2000-11-15 Glaxo Group Limited NK-1 receptor antagonist and a systemic antiinflammatory corticosteroid for the treatment of emesis
IL106142A (en) * 1992-06-29 1997-03-18 Merck & Co Inc Morpholine and thiomorpholine tachykinin receptor antagonists, their preparation and pharmaceutical compositions containing them
IL111960A (en) * 1993-12-17 1999-12-22 Merck & Co Inc Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them
EP0737192B1 (en) * 1993-12-29 2001-10-31 Merck Sharp & Dohme Ltd. Substituted morpholine derivatives and their use as therapeutic agents
TW385308B (en) * 1994-03-04 2000-03-21 Merck & Co Inc Prodrugs of morpholine tachykinin receptor antagonists
ES2194937T3 (es) * 1995-03-24 2003-12-01 Takeda Chemical Industries Ltd Compuestos ciclicos, su produccion y uso como antagonistas de los receptores de taquiquinina.
US5972938A (en) * 1997-12-01 1999-10-26 Merck & Co., Inc. Method for treating or preventing psychoimmunological disorders
SE1035115T5 (sv) * 1999-02-24 2015-08-04 Hoffmann La Roche 4-fenylpyridin-derivat och deras anvaendning som NK-1 receptor-antagonister
US6303790B1 (en) * 1999-11-29 2001-10-16 Hoffman-La Roche Inc. Process for the preparation of pyridine derivatives
MXPA03000366A (es) * 2000-07-14 2003-05-27 Hoffmann La Roche N-oxidos como profarmacos antagonistas del receptor nk1 de derivados de 4-fenil-piridina.
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives

Also Published As

Publication number Publication date
DE10058310A1 (de) 2001-05-31
DK1103545T3 (da) 2004-03-15
ES2208205T3 (es) 2004-06-16
ES2171134A1 (es) 2002-08-16
AU7178700A (en) 2001-05-31
HU224703B1 (en) 2006-01-30
CN1297888A (zh) 2001-06-06
GB0028566D0 (en) 2001-01-10
JP3480835B2 (ja) 2003-12-22
IS5725A (is) 2001-05-29
EA200001114A2 (ru) 2001-08-27
MA26754A1 (fr) 2004-12-20
IL139868A0 (en) 2002-02-10
OA11513A (fr) 2004-02-03
DE60006340T2 (de) 2004-09-09
FR2801590A1 (fr) 2001-06-01
IL139868A (en) 2009-09-01
CZ299286B6 (cs) 2008-06-04
HK1036759A1 (en) 2002-01-18
PL195957B1 (pl) 2007-11-30
MY127426A (en) 2006-11-30
SK285373B6 (sk) 2006-12-07
UA70326C2 (en) 2004-10-15
CA2326529C (en) 2009-12-22
DOP2000000106A (es) 2002-07-30
BRPI0005616B1 (pt) 2017-12-12
EA200001114A3 (ru) 2001-12-24
ITMI20002575A1 (it) 2002-05-29
NO317264B1 (no) 2004-09-27
KR20010051983A (ko) 2001-06-25
TNSN00226A1 (fr) 2002-05-30
MXPA00011672A (es) 2002-08-20
ATE253561T1 (de) 2003-11-15
UY26458A1 (es) 2001-05-31
CN1152016C (zh) 2004-06-02
BRPI0005616B8 (pt) 2021-07-06
EP1103545B1 (en) 2003-11-05
NZ508386A (en) 2003-02-28
HUP0004725A2 (hu) 2002-04-29
NO20006012L (no) 2001-05-30
IS2212B (is) 2007-02-15
ZA200006964B (en) 2001-06-05
EA004404B1 (ru) 2004-04-29
SI1103545T1 (en) 2004-02-29
SV2002000227A (es) 2002-02-05
HU0004725D0 (hu) 2001-02-28
KR100390117B1 (ko) 2003-07-04
AR033659A1 (es) 2004-01-07
YU73400A (sh) 2003-02-28
BG64622B1 (bg) 2005-09-30
GEP20022763B (en) 2002-08-26
GB2356863A (en) 2001-06-06
DE60006340D1 (de) 2003-12-11
PT1103545E (pt) 2004-03-31
ID28483A (id) 2001-05-31
BR0005616A (pt) 2001-07-17
GT200000197A (es) 2002-05-22
EP1103545A1 (en) 2001-05-30
SK17932000A3 (sk) 2001-11-06
AU775292B2 (en) 2004-07-29
JP2001151754A (ja) 2001-06-05
HRP20000809A2 (en) 2001-12-31
TR200302077T4 (tr) 2004-01-21
BG104992A (en) 2001-11-30
PA8507201A1 (es) 2002-02-21
JO2298B1 (en) 2005-09-12
SG97171A1 (en) 2003-07-18
CO5251405A1 (es) 2003-02-28
CA2326529A1 (en) 2001-05-29
PL344147A1 (en) 2001-06-04
CZ20004399A3 (cs) 2001-07-11
NO20006012D0 (no) 2000-11-28
IT1320120B1 (it) 2003-11-18
PE20010901A1 (es) 2001-09-20

Similar Documents

Publication Publication Date Title
GC0000151A (en) 2-(3,5-Bis-trifluoromethyl-phenyl)-n-methyl-n-(6-morpholin-4-o-tolyl-pyridin-3-yl)-isobutyramide.
IL162721A0 (en) 2-(Pyridin-2-ylamino)-pyridoÄ2,3-dÜpyrimidin-7-ones
AP2001002230A0 (en) 2-(4-Pyridyl) amino-6- dialkoxyphenyl-pyrido ¬2,3-d¾ pyrimidin-7-0 nes
GC0000108A (en) 4-Amino substituted-2-substituted-1,2,3,4-tetrahy droquinolines.
MX244506B (es) Herbicidas de piridina sustituidas.
IL163817A0 (en) 2,4-Diaminopyrimidine
PT1056759E (pt) Derivados do 2-(purin-9-il)-tetrahidrofurano-3,4-diolc
AU2003275716A1 (en) 3-benzoyl-2,4,5-substituted pyridine derivatives or salts thereof and bactericides containing the same
GB2361235B (en) 2,2,6,6 Diethyl-dimethyl-1-alkoxy-piperidine compounds and their corresponding 1-oxides
AU2003266333A8 (en) 4-(3,3-dihalo-allyloxy) phenol derivatives having pesticidal properties
IL139115A0 (en) 2-(2-methylphenyl)-3,4-dihydro-2h-pyrrol derivatives
ZA996615B (en) Truss with alternating metal web.
MX223829B (es) Benzoilpirazoles sustituidos como herbicidas.
AU3819200A (en) 2,4-diamino-pyrimidine derivatives
ZA200400652B (en) 2-(3,5-Bis-trifluoromethyl-phenyl)-N-[6-((1,1-dioxo-1lambda6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide.
DE60025958D1 (de) 14,15-beta-methylen substituierte androgene
ZA986189B (en) Substituted 2-(benzaryl)pyridines.
AR027974A1 (es) 1-aril-ciclopropilmetilamino-1,3,5-triazinas substituidas
GB0012376D0 (en) 3,4,5-tricyanophenyl derivatives
AU144459S (en) Personal computer.
IL159571A0 (en) 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1,-DIOXO-1lamda6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED) PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
GB9909482D0 (en) 2-(Purin-9-yl)-tetahydrofuran-3,4-diol derivatives
ZA200101663B (en) Hinge arrangement.
ZA200209995B (en) Friction hinge.